Tech Company Financing Transactions

Aprecia Pharmaceuticals Funding Round

Deerfield Capital, JW Asset Management and private investors participated in a $35 million funding round for Aprecia Pharmaceuticals. The funding round was announced on 1/27/2016.

Transaction Overview

Company Name
Aprecia Pharmaceuticals
Announced On
1/27/2016
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Undisclosed
Investors

Deerfield Capital (Lead Investor) (Jonathan Leff)

JW Asset Management

Proceeds Purpose
In connection with the financing, all of the company's outstanding convertible debt held by its existing investors, including Great American Insurance Company and Scion Companies, was converted into preferred stock. Proceeds will support the company's efforts to advance the commercialization of SPRITAM (levetiracetam) through an exclusive sales and marketing alliance with inVentiv Health, as well as accelerate the development of additional 3D printed drug formulations utilizing ZipDose Technology, Aprecia's novel 3DP technology platform. SPRITAM, the world's first 3D printed medicine approved by the US Food and Drug Administration, is expected to launch in the first half of 2016.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10901 Kenwood Rd.
Blue Ash, OH 45242
USA
Phone
(513) 984-5000
Website
www.aprecia.com
Email Address
[email protected]
Overview
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Profile
Aprecia Pharmaceuticals LinkedIn Company Profile
Social Media
Aprecia Pharmaceuticals Company Twitter Account
Company News
Aprecia Pharmaceuticals News
Facebook
Aprecia Pharmaceuticals on Facebook
YouTube
Aprecia Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Thomas Arington
  Thomas Arington LinkedIn Profile  Thomas Arington Twitter Account  Thomas Arington News  Thomas Arington on Facebook
Chief Executive Officer
Christopher Gilmore
  Christopher Gilmore LinkedIn Profile  Christopher Gilmore Twitter Account  Christopher Gilmore News  Christopher Gilmore on Facebook
Chief Financial Officer
Mike Rohlfs
  Mike Rohlfs LinkedIn Profile  Mike Rohlfs Twitter Account  Mike Rohlfs News  Mike Rohlfs on Facebook
Chief Technical Officer
Jaedeok Yoo
  Jaedeok Yoo LinkedIn Profile  Jaedeok Yoo Twitter Account  Jaedeok Yoo News  Jaedeok Yoo on Facebook
Vice President
Don Wetherhold
  Don Wetherhold LinkedIn Profile  Don Wetherhold Twitter Account  Don Wetherhold News  Don Wetherhold on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/27/2016: Moz venture capital transaction
Next: 1/27/2016: Sure venture capital transaction

 

Share this article

 

About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.